Copper-specific damage in human erythrocytes exposed to oxidative stress.
Ascorbate and complexes of Cu(II) and Fe(III) are capable of generating significant levels of oxygen free radicals. Exposure of erythrocytes to such oxidative stress leads to increased levels of methemoglobin and extensive changes in cell morphology. Cu(II) per mole is much more effective than Fe(III). However, isolated hemoglobin is oxidized more rapidly and completely by Fe(III)- than by Cu(II)-complexes. Both Fe(III) and Cu(II) are capable of inhibiting a number of the key enzymes of erythrocyte metabolism. The mechanism for the enhanced activity of Cu(II) has not been previously established. Using intact erythrocytes and hemolysates we demonstrate that Cu(II)-, but not Fe(III)-complexes in the presence of ascorbate block NADH-methemoglobin reductase. Complexes of Cu(II) alone are not inhibitory. The relative inability of Fe(III)-complexes and ascorbate to cause methemoglobin accumulation is not owing to Fe(III) association with the membrane, or its failure to enter the erythrocytes. The toxicity of Cu(II) and ascorbate appears to be a result of site-specific oxidative damage of erythrocyte NADH-methemoglobin reductase and the enzyme's subsequent inability to reduce the oxidized hemoglobin.
Clopton
D A
DA
Department of Biology, University of California San Diego, La Jolla 92093-0322, USA.
Saltman
P
P
D003300:Copper / Q000009:adverse effects / Q000097:blood / Q000633:toxicity*; D042966:Cytochrome-B(5) Reductase / Q000097:blood / Q000187:drug effects; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D006454:Hemoglobins / Q000737:chemistry / Q000187:drug effects; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008706:Methemoglobin / Q000737:chemistry / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology
D006454:Hemoglobins; D003300:Copper; D008706:Methemoglobin; D042966:Cytochrome-B(5) Reductase